The Technical Analyst
Select Language :
Antares Pharma Inc [ATRS]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies

Antares Pharma Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Antares Pharma Inc is listed at the  Exchange

0.18% $5.59

America/New_York / 31 des 1970 @ 19:00


Antares Pharma Inc: Main Fundamentals PE comparison

RATING 2022-05-24
B+
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 14.95 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.45x
Company: PE 14.95 | industry: PE 33.06
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 5.49 - 5.69

( +/- 1.86%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-05-24 Gueth Anton Sell 79 645 Common Stock
2022-05-24 Gueth Anton Sell 61 930 Stock Option (right to buy)
2022-05-24 Gueth Anton Sell 99 395 Stock Option (right to buy)
2022-05-24 Gueth Anton Sell 150 000 Stock Option (right to buy)
2022-05-24 Gueth Anton Sell 80 318 Stock Option (right to buy)
INSIDER POWER
-100.00
Last 97 transactions
Buy: 1 667 582 | Sell: 3 999 780

Forecast: 01:40 - $5.52

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.59 (0.18% )
Volume 1.763 mill
Avg. Vol. 5.23 mill
% of Avg. Vol 33.72 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Antares Pharma Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Antares Pharma Inc

RSI

Intraday RSI14 chart for Antares Pharma Inc

Last 10 Buy & Sell Signals For ATRS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Antares Pharma Inc

ATRS

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. As of May 23, 2022, Antares Pharma, Inc. operates as a subsidiary of Halozyme Therapeutics, Inc.

Last 10 Buy Signals

Date Signal @
PEPECOINUSDMar 29 - 02:245.83
VRXUSDMar 29 - 02:1960.44
^N300Mar 29 - 02:00594.52
CBKUSDMar 29 - 02:151.087
ORCAUSDMar 29 - 02:153.83
TRXUSDMar 29 - 02:10$0.120
BADGERUSDMar 29 - 02:117.11
INDEXUSDMar 29 - 02:085.97
FUMOUSDMar 29 - 02:109 998.30
FTNUSDMar 29 - 02:101.819

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.